comparemela.com

Latest Breaking News On - Khiron chief financial officer - Page 1 : comparemela.com

Khiron Life Sciences Corp.: Khiron Life Sciences Reports Third Quarter 2022 Financial Results

In Europe, revenues increased by 141% year-over-year, driven by revenues in the United Kingdom, where the Corporation is now increasing its existing product portfolio, and the specialized cannabis

Germany
Rio-de-janeiro
Estado-do-rio
Brazil
United-states
United-kingdom
Colombia
Peru
Canada
Toronto
Ontario
Switzerland

Khiron Life Sciences Reports Third Quarter 2022 Financial Results

In Europe, revenues increased by 141% year-over-year, driven by revenues in the United Kingdom, where the Corporation is now increasing its existi.

Germany
Rio-de-janeiro
Estado-do-rio
Brazil
United-states
United-kingdom
Colombia
Peru
Canada
Toronto
Ontario
Switzerland

Khiron to Host Third Quarter 2022 Conference Call on November 30, 2022

/PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMXC), the global leader in medical cannabis.

Mexico
Germany
United-states
United-kingdom
Brazil
Colombia
Peru
Toronto
Ontario
Canada
America
Franziska-katterbach

Khiron Life Sciences Reports Second Quarter 2022 Financial Results

Reports revenues of $9.1 million in the first half of 2022, up 62% year-over-year, reflecting continued medical cannabis momentum in target market.

Mexico
Germany
Rio-de-janeiro
Estado-do-rio
Brazil
United-states
United-kingdom
Bogota
Cundinamarca
Colombia
Peru
Canada

Khiron to Host Second Quarter 2022 Conference Call on August 29, 2022

/PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN)(OTCQX: KHRNF)(Frankfurt: A2JMXC), the global leader in medical cannabis.

Mexico
Germany
United-states
United-kingdom
Brazil
Colombia
Peru
Toronto
Ontario
Canada
America
Franziska-katterbach

vimarsana © 2020. All Rights Reserved.